Skip to content
Aurenex

Clinical development

Risk surfaced while there is still time to act

Feasibility modelling, cross-source anomaly detection and site intelligence that turn monthly status reviews into continuous operational awareness.

How we approach it

Three commitments we hold to

01

Design before lock

Protocol burden and amendment risk are modelled while the design can still change.

02

Signal, not noise

Escalations arrive with the exact records that triggered them and a false-positive review loop.

03

Submission-ready lineage

Every derived dataset carries lineage a reviewer can follow end to end.

Agents

Agents that work in this domain

Services

How engagements are structured

Life Sciences Expertise

Clinical Development

From protocol feasibility through to submission, we operationalise clinical data so that quality signal surfaces early and every derived dataset carries lineage a regulator can follow.

  • CDISC-aligned clinical data products
  • Risk-based monitoring analytics
  • Site and enrolment forecasting
  • Submission traceability tooling

Engineering Expertise

Quality & Compliance

We embed validation and control design into delivery rather than bolting it on: computerised system validation, audit trails, access governance and documented AI risk assessment.

  • GxP validation packages
  • Audit trail and access governance
  • AI risk assessment frameworks
  • SOP and control documentation

FAQ

Questions we are usually asked

Next step

Bring a real problem. We will bring the architecture.

Thirty minutes with our architects is usually enough to tell whether a programme is ready for agents, or whether the data foundation needs work first.

Talk to an architect
See the work